node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
H3ACE0_LATCH | MYOG | ENSLACP00000007311 | ENSLACP00000016886 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Myogenin. | 0.527 |
LFNG | LOC102357987 | ENSLACP00000017114 | ENSLACP00000014598 | Beta-1,3-N-acetylglucosaminyltransferase. | Uncharacterized protein. | 0.917 |
LOC102352268 | SMAD3 | ENSLACP00000019574 | ENSLACP00000011989 | Transforming growth factor beta; Belongs to the TGF-beta family. | Mothers against decapentaplegic homolog. | 0.418 |
LOC102352268 | SMAD6 | ENSLACP00000019574 | ENSLACP00000006043 | Transforming growth factor beta; Belongs to the TGF-beta family. | Mothers against decapentaplegic homolog. | 0.411 |
LOC102352268 | SMAD7 | ENSLACP00000019574 | ENSLACP00000006551 | Transforming growth factor beta; Belongs to the TGF-beta family. | Mothers against decapentaplegic homolog. | 0.525 |
LOC102352268 | TGFBR2 | ENSLACP00000019574 | ENSLACP00000004468 | Transforming growth factor beta; Belongs to the TGF-beta family. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.990 |
LOC102357987 | LFNG | ENSLACP00000014598 | ENSLACP00000017114 | Uncharacterized protein. | Beta-1,3-N-acetylglucosaminyltransferase. | 0.917 |
MYOG | H3ACE0_LATCH | ENSLACP00000016886 | ENSLACP00000007311 | Myogenin. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.527 |
MYOG | PAX7 | ENSLACP00000016886 | ENSLACP00000021802 | Myogenin. | Paired box 7. | 0.751 |
MYOG | TGFBR2 | ENSLACP00000016886 | ENSLACP00000004468 | Myogenin. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.584 |
PAX7 | MYOG | ENSLACP00000021802 | ENSLACP00000016886 | Paired box 7. | Myogenin. | 0.751 |
SMAD3 | LOC102352268 | ENSLACP00000011989 | ENSLACP00000019574 | Mothers against decapentaplegic homolog. | Transforming growth factor beta; Belongs to the TGF-beta family. | 0.418 |
SMAD3 | SMAD6 | ENSLACP00000011989 | ENSLACP00000006043 | Mothers against decapentaplegic homolog. | Mothers against decapentaplegic homolog. | 0.946 |
SMAD3 | SMAD7 | ENSLACP00000011989 | ENSLACP00000006551 | Mothers against decapentaplegic homolog. | Mothers against decapentaplegic homolog. | 0.959 |
SMAD3 | TGFBR2 | ENSLACP00000011989 | ENSLACP00000004468 | Mothers against decapentaplegic homolog. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.980 |
SMAD6 | LOC102352268 | ENSLACP00000006043 | ENSLACP00000019574 | Mothers against decapentaplegic homolog. | Transforming growth factor beta; Belongs to the TGF-beta family. | 0.411 |
SMAD6 | SMAD3 | ENSLACP00000006043 | ENSLACP00000011989 | Mothers against decapentaplegic homolog. | Mothers against decapentaplegic homolog. | 0.946 |
SMAD6 | SMAD7 | ENSLACP00000006043 | ENSLACP00000006551 | Mothers against decapentaplegic homolog. | Mothers against decapentaplegic homolog. | 0.947 |
SMAD6 | TGFBR2 | ENSLACP00000006043 | ENSLACP00000004468 | Mothers against decapentaplegic homolog. | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] | 0.742 |
SMAD7 | LOC102352268 | ENSLACP00000006551 | ENSLACP00000019574 | Mothers against decapentaplegic homolog. | Transforming growth factor beta; Belongs to the TGF-beta family. | 0.525 |